Clinical trials
Completed Observational Homocystinuria trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre Hospitalier Universitaire de Liege | 1 |
| National Center for Research Resources (NCRR) | 1 |
| Travere Therapeutics, Inc. | 1 |
| University of Lausanne | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Homocystinuria | 4 |
| Adrenal Hyperplasia, Congenital | 1 |
| Adrenoleukodystrophy | 1 |
| Andersen Syndrome | 1 |
| Anemia, Diamond-Blackfan | 1 |
| Anemia, Sickle Cell | 1 |
| Argininosuccinic Aciduria | 1 |
| Aspartylglucosaminuria | 1 |
| Biotinidase Deficiency | 1 |
| Carbamoyl-Phosphate Synthase I Deficiency Disease | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.